IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Flagship Pioneering, LLC

Q1 2018 Holdings

Filed 2018-05-15 | 4 holdings | $344.9K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Denali Therapeutics Inc(DNLI)COM24823R105$175.6K8,918,74950.9%
Seres Therapeutics Inc(MCRB1EUR)COM81750R102$93.1K12,682,87627.0%
Syros Pharmaceuticals IncCOM87184Q107$41.6K3,204,43712.1%
Quanterix Corp(QTRX)COM74766Q101$34.6K2,030,49510.0%